BD and Babson Diagnostics today announced the results of new studies demonstrating that blood tests commonly used in wellness checks and chronic disease management are just as accurate when using several drops of blood collected from a finger prick as when the sample is taken from a vein. The novel BD MiniDraw Capillary Blood Collection technology used in the studies, which is a key enabler in Babson’s BetterWay blood testing service, provides a patient-friendly alternative to venipuncture and expands access to more convenient locations.
Three studies evaluated accuracy and within-tube stability over time for fingertip capillary blood samples collected, processed, transported and stored using the BD MiniDraw Capillary Blood Collection System along with BD MiniDraw SST Capillary Blood Collection Tube versus blood samples obtained via venous and conventional capillary collection methods by a licensed phlebotomist. A peer-reviewed article published in the Journal of Applied Laboratory Medicine showed that capillary collection using the BD MiniDraw Capillary Blood Collection System was clinically equivalent to conventional collection methods for selected general chemistry analytes used frequently in wellness checks and for diagnosing and monitoring some chronic conditions, including kidney, liver and cardiac diseases.
Babson’s BetterWay, which includes proprietary technologies in collection, preparation and analysis of blood samples, uses BD's MiniDraw Capillary Blood Collection System. This innovative blood testing process enables samples to be collected and prepared by any trained health care worker — including those without prior phlebotomy experience.
